Health Hazard Evaluation
Structured assessment of patient/user risk used to support recall classification and field-action decisions.
Definition
An HHE evaluates the disease/condition affected, severity of consequence, probability of occurrence, exposed population, and mitigations. The output supports recall classification (I/II/III) and the urgency of customer notification. HHEs are usually done by a cross-functional team, including clinical or medical input, and should be based on facts from complaints, investigations and risk management files. The conclusions decide whether an action is a recall, its classification and the depth of notification. FDA performs its own health hazard evaluation when classifying a recall, and differences from the firm's view can lead to a higher class.What this means in practice
FDA recall coordinators frequently require an updated HHE during recall negotiation; pre-built templates accelerate response.Examples
- A manufacturer performs an HHE after discovering a software bug that could cause inaccurate therapy delivery, determining a Class I recall is necessary due to potential serious injury or death.
- Following a customer complaint of device malfunction, an HHE assesses the likelihood of patient harm to classify a recall as Class II, requiring device correction and customer notification.
- An HHE is conducted for a labeling error that does not directly impact device function or patient safety, resulting in a Class III recall for minor product correction.
- •Failing to update an HHE when new information or complaints emerge can lead to an incorrect recall classification.
- •Underestimating the severity of a health consequence can result in an inadequate recall strategy.
- •Not clearly documenting the HHE methodology and conclusions can lead to regulatory scrutiny.
- •Confusing a health hazard evaluation with a routine risk assessment can misdirect post-market activities.
- •Delaying the completion of an HHE can prolong patient exposure to hazardous products and worsen regulatory outcomes.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Post-Market
· Same categoryExpedited FDA MDR for events requiring remedial action to prevent unreasonable risk of substantial harm.
Yearly report required for Class III PMA devices summarizing changes, complaints, and post-approval study status.
Communication to users notifying them of a safety issue, corrective action, or important product information.
FDA's mandatory electronic submission system for Medical Device Reports.
Where this term appears across MedTech Terms.
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 121 CFR Part 7, RecallsTier 1 UncheckedFDAecfr.gov
- 2EUDAMED Public SiteTier 2 VerifiedEuropean Commissionec.europa.eu
- 3MDCG Vigilance GuidanceTier 2 VerifiedMDCGhealth.ec.europa.eu
Inline markers like [1] jump to the matching reference above.